Skip to main content
Clinical Trials/NCT04914299
NCT04914299WithdrawnNot Applicable

Positive Intelligence - Prospective Study Evaluating a Novel Mobile App Based Preventive Behavioral Intervention for Perinatal Mood Disorders

Massachusetts General Hospital0 sites400 target enrollmentStarted: July 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Enrollment
400
Primary Endpoint
Postpartum Depression Symptoms

Study Overview

Brief Summary

The primary aim of the study is to investigate whether a novel mobile App-based behavioral intervention in pregnant women can: (1) prevent and/or decrease the incidence of perinatal mood disorders (2) decrease the severity and/or duration of perinatal mood disorders in affected participants (3) increase access of pregnant women to behavioral intervention and support tools (4) increase the satisfaction of pregnant women with their prenatal care.

Detailed Description

Perinatal depression is an episode of major or minor depression that occurs during pregnancy or in the 12 months after birth; it affects about 10% of new mothers. Postpartum depression accounts for 12.5% of psychologically related hospitalizations among women.

In 2019, the United States Preventive Services Task Force (USPSTF) recommended screening pregnant women to identify those at risk for perinatal depression and refer them for counseling. The USPSTF recommendation is based on growing literature indicating that counseling women at risk for perinatal depression reduce the risk of having an episode of major depression by 40%.

Supporting that, multiple studies have shown that cognitive-behavioral intervention and mental health care adjuvant therapy can effectively improve the condition of patients with postpartum depression. Finally, access to care has also been shown to be an important factor in determining the success of any intervention. Women across high and low-risk groups often have barriers to treatment due to stigma, shame, and fear to disclose symptoms to health providers

In this research, the investigators aim to investigate whether a novel mobile App-based behavioral intervention can meaningfully increase access and demonstrate a beneficial effect in preventing anxiety and depression in the postpartum period. Furthermore and adding to the existing literature in post-partum depression, this study aims to investigate the role of "positive intelligence", an integrative positive cognitive behavioral therapy, as a tool in the prevention and treatment of perinatal mood disorders.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Able to read and speak English
  • Have a low-risk singleton pregnancy with more than 24 weeks of gestation
  • Have smartphone with internet access
  • Failure to meet criteria for a diagnosis of MDD in the last two months

Exclusion Criteria

  • Physical or mental disorders which would interfere with their ability to participate in the study
  • High-risk pregnancy
  • Give birth to a newborn at still-birth or a newborn with congenital anomalies and/or Medical complications that require special care in hospital
  • Infant has a birth weight lower than 2,500 grams
  • Infant has a 5-minute Apgar score lower than 7

Outcomes

Primary Outcomes

Postpartum Depression Symptoms

Time Frame: 3rd trimester pregnancy till 6 months postpartum

Postpartum Depression Symptoms measured by Edinburgh Postnatal Depression Scale postpartum. Scale 1-30,with 0 indicating no symptoms, and 30 indicating the highest severity of symptoms.

Secondary Outcomes

  • Patient Satisfaction(6 weeks postpartum to 6 months postpartum)
  • Generalized Anxiety Symptoms(3rd trimester pregnancy till 6 months postpartum)
  • Completion of App-based intervention program(6 weeks postpartum)
  • Patient depression symptoms and severity(3rd trimester pregnancy till 6 months postpartum)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Shay Erisson

Physician, Obstetrics and Gynecology

Massachusetts General Hospital

Similar Trials

Prospective Study Evaluating a Novel... | Clinical Trial